2016–Present: Assistant Professor of Medicinal Chemistry, Department of BioMolecular Sciences, School of Pharmacy, University of Mississippi
2016–Present: Research Assistant Professor, Research Institute of Pharmaceutical Sciences
School of Pharmacy, University of Mississippi
2020–Present: Member, UMMC Cancer Center and Research Institute
2019–2021: Graduate Program Coordinator, Medicinal Chemistry Division, Department of BioMolecular Sciences, School of Pharmacy, University of Mississippi
2018–2019: Visiting Scientist, St. Jude Children's Research Hospital
Postdoctoral Researcher, Northwestern University (2013 - 2016). Advisor: Richard Silverman
Ph.D., Cornell University, 2013. Advisor: Bruce Ganem
B.S., University of California, Berkeley, 2008. Advisor: Kenneth Raymond
2021: P2 Teaching Team of the Year Award (Team Member), UM School of Pharmacy
2020: P1 Teaching Team of the Year Award (Team Leader), UM School of Pharmacy
2018: New Investigator Award, American Association of Colleges of Pharmacy (AACP)
2010–2012: NIH Chemistry/Biology Interface Training Grant
Co-inventor of OV329, licensed to OVID Therapeutics 2016-Present
10/2011–11/2011: Avila Therapeutics, Inc. (now part of Bristol Myers Squibb)
2021–2022: Topic Editor, "Targeting Cancer Metabolic Reprogramming for Cancer Therapy", Frontiers in Drug Discovery
2021–Present: Associate Editor, Frontiers in Drug Discovery
2022: Reviewer, NSF Graduate Research Fellowships Program (GRFP)
2021: Reviewer, NSF SBIR/STTR program
2021: Reviewer, NSF Graduate Research Fellowships Program (GRFP)
2020: Reviewer, NSF Graduate Research Fellowships Program (GRFP)
2019: Reviewer, NSF Graduate Research Fellowships Program (GRFP)
2018: Reviewer, Innovational Research Incentive Scheme – Veni Programme
2017: Reviewer, NIH Macromolecular Structure and Function A Study Section
2017: NIH Early Career Reviewer Program
2022: ACS Leadership Institute
2022: Member, AACP Chemistry Section Awards Committee
2021–2022: Chair-Elect, American Chemical Society Local Section, University of Mississippi
2021–2022: Vice Chair, Research and Graduate Affairs Committee, School of Pharmacy, University of Mississippi
2021–Present: Member, UM Mentoring Working Group
2021–Present: Member, UM Graduate School's Graduate Student Mental Health and Well-being Advisory Board
2021: Member, AACP Chemistry Section Awards Committee
2018–2021: Secretary (elected in 2018; re-elected in 2019 and 2020), American Chemical Society Local Section, University of Mississippi
2020–2021: Vice Chair, Research and Graduate Affairs Committee, School of Pharmacy, University of Mississippi
2019–Present: Faculty Advisor, Ole Miss Vietnamese American Student Association (Ole VASA)
2019–2020: Member, AACP New Investigator Awards Review Committee
2019–2020: Vice Chair, Research and Graduate Affairs Committee, School of Pharmacy, University of Mississippi
2017–2021: Founder and Director, Science, Technology, Engineering and Math Summer Research Experience for Undergraduates (STEMS REU) Program, University of Mississippi
2016–2019: Member, Research and Graduate Affairs Committee, School of Pharmacy, University of Mississippi
2022: Poster Judge, MALTO Medicinal Chemistry and Pharmacognosy Meeting-in-Miniature
2022: Poster Abstract Reviewer, 2022 AACP Annual Meeting
2022: National Research Mentoring Network (NRMN)'s Grant Writing Coaching Program
2021: Poster Abstract Reviewer, Virtual Pharmacy Education: The 2021 AACP Annual Meeting
2021: Judge, Regional Science Fair for Elementary Schools
2018: NIGMS Mentoring Workshop for New Faculty in Organic and Biological Chemistry
2018: NSF Chemistry Early Career Investigator Workshop
2018: Poster Judge, MALTO Medicinal Chemistry and Pharmacognosy Meeting-in-Miniature
2018–Present: Member, Experimental Therapeutics Group, UMMC Cancer Center and Research Institute
2018: Poster Judge, Southeastern Undergraduate Research Conference (SURC)
2017: Poster Judge, MALTO Medicinal Chemistry and Pharmacognosy Meeting-in-Miniature
2015: NIH Training in Neurotherapeutics Discovery and Development for Academic Scientists
The Rho Chi Society (the Academic Honor Society in Pharmacy)
American Association of Colleges of Pharmacy
American Chemical Society (Divisions of Medicinal Chemistry and Organic Chemistry)
University of Mississippi
13) Le, H. V.; Hossain, M. I. U.S. Patent Application 17,597,550 (filed January 11, 2022). L-γ-methyleneglutamine compounds and methods of use
Northwestern University
12) Silverman, R. B.; Takaya, K.; Le, H. V.; Juncosa, J. I. India Patent IN 372532 (July 23, 2021). (S)-3-amino-4-(difluoromethylenyl)cyclopent-1-ene-1-carboxylic acid, and related compounds as GABA aminotransferase inactivators for the treatment of epilepsy, addiction, and hepatocellular carcinoma
11) Silverman, R. B.; Takaya, K.; Le, H. V.; Juncosa, J. I. Australia Patent AU 2016334396 (July 22, 2021). (S)-3-amino-4-(difluoromethylenyl)cyclopent-1-ene-1-carboxylic acid, and related compounds as GABA aminotransferase inactivators for the treatment of epilepsy, addiction, and hepatocellular carcinoma
10) Silverman, R. B.; Juncosa, J.; Le, H. V.; Takaya, K. Israel Patent IL 258516 (April 1, 2021). (S)-3-Amino-4-(difluoromethylenyl)cyclopent-1-ene-1-carboxylic acid, a highly potent GABA aminotransferase inactivator for the treatment of epilepsy, addiction, and hepatocellular carcinoma
9) Silverman, R. B.; Juncosa, J.; Le, H. V.; Takaya, K. Japan Patent JP 6841821 (February 22, 2021). (S)-3-Amino-4-(difluoromethylenyl)cyclopent-1-ene-1-carboxylic acid, and related compounds as GABA aminotransferase inactivators for the treatment of epilepsy, addiction, and hepatocellular carcinoma
8) Silverman, R. B.; Juncosa, J.; Le, H. V.; Takaya, K. China Patent ZL 2016800590699 (February 12, 2021). (S)-3-Amino-4-(difluoromethylenyl)cyclopent-1-ene-1-carboxylic acid, a highly potent GABA aminotransferase inactivator for the treatment of epilepsy, addiction, and hepatocellular carcinoma
7) Silverman, R. B.; Le, H. V.; Hawker, D. D. U.S. Patent 10,800,753 B2 (October 13, 2020). Tetrahydrothiophene-based GABA aminotransferase inactivators and analogs thereof for treating neurological disorders
6) Silverman, R. B.; Le, H. V.; McLeod, R. L.; Hawker, D. D. U.S. Patent 10,632,088 B2 (April 28, 2020). Inactivators of Toxoplasma gondii ornithine aminotransferase for treating toxoplasmosis and malaria
5) Juncosa, J.; Le, H. V.; Silverman, R. B.; Takaya, K., Columbia Patent Certificado Numero 37025 (April 17, 2020). Compuestos derivados del ácido (S)-3-amino-4-(difluorometilenil)ciclopent-1-eno-1-carboxílico como inhibidores de GABA aminotransferase
4) Silverman, R. B.; Le, H. V.; Hawker, D. D. U.S. Patent 10,189,807 B2 (January 29, 2019). Tetrahydrothiophene-based GABA aminotransferase inactivators
3) Silverman, R. B.; Takaya, K.; Le, H. V.; Juncosa, J. I. U.S. Patent 9,993,449 B2 (June 12, 2018). (S)-3-Amino-4-(difluoromethylenyl)cyclopent-1-ene-1-carboxylic acid, and related compounds as GABA aminotransferase inactivators for the treatment of epilepsy, addiction, and hepatocellular carcinoma
2) Silverman, R. B.; Hawker, D. D.; Le, H. V. U.S. Patent 9,856,231 B2 (January 2, 2018). Tetrahydrothiophene-based GABA aminotransferase inactivators
1) Silverman, R. B.; Takaya, K.; Le, H. V.; Juncosa, J. I. U.S. Patent 9,670,141 B2 (June 6, 2017). (S)-3-Amino-4-(difluoromethylenyl)cyclopent-1-ene-1-carboxylic acid, and related compounds as GABA aminotransferase inactivators for the treatment of epilepsy, addiction, and hepatocellular carcinoma
Copyright © 2022 Hoang Le Research Group at the University of Mississippi - All Rights Reserved.
Powered by GoDaddy
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.